Page last updated: 2024-08-24

1,2-distearoyllecithin and Colorectal Cancer

1,2-distearoyllecithin has been researched along with Colorectal Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, S; Erdoğ, A; Keskin, D; Putra Limasale, YD; Tezcaner, A1
Franzen, U; Gammelgaard, B; Nguyen, TT; Ostergaard, J; Vermehren, C1

Other Studies

2 other study(ies) available for 1,2-distearoyllecithin and Colorectal Cancer

ArticleYear
In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:10

    Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Colorectal Neoplasms; Drug Delivery Systems; HCT116 Cells; HT29 Cells; Humans; Liposomes; Phosphatidylcholines; Polyethylene Glycols; Pyrazoles; Sulfonamides

2013
Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage.
    Journal of pharmaceutical and biomedical analysis, 2011, Apr-28, Volume: 55, Issue:1

    Topics: Algorithms; Antineoplastic Agents; Colorectal Neoplasms; Drug Compounding; Drug Delivery Systems; Drug Stability; Electrophoresis, Capillary; Liposomes; Organoplatinum Compounds; Oxaliplatin; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Solubility; Spectrophotometry, Atomic

2011